Antifibrinolytics in subarachnoid haemorrhage

Alejandro A. Rabinstein

doi:10.1016/S0140-6736(20)32636-2

Antifibrinolytics in subarachnoid haemorrhage

Neurology

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	74-75
Number of pages	2
Journal	The Lancet
Volume	397
Issue number	10269
DOIs	https://doi.org/10.1016/S0140-6736(20)32636-2
State	Published - Jan 9 2021

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/S0140-6736(20)32636-2

Cite this

@article{e0aafc183b1c4d8d80b60b0edf293bc5,

title = "Antifibrinolytics in subarachnoid haemorrhage",

author = "Rabinstein, {Alejandro A.}",

year = "2021",

month = jan,

day = "9",

doi = "10.1016/S0140-6736(20)32636-2",

language = "English (US)",

volume = "397",

pages = "74--75",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier Limited",

number = "10269",

}

TY - JOUR

T1 - Antifibrinolytics in subarachnoid haemorrhage

AU - Rabinstein, Alejandro A.

PY - 2021/1/9

Y1 - 2021/1/9

UR - http://www.scopus.com/inward/record.url?scp=85098760390&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85098760390&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(20)32636-2

DO - 10.1016/S0140-6736(20)32636-2

M3 - Comment/debate

C2 - 33357468

AN - SCOPUS:85098760390

SN - 0140-6736

VL - 397

SP - 74

EP - 75

JO - The Lancet

JF - The Lancet

IS - 10269

ER -

Antifibrinolytics in subarachnoid haemorrhage

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this